監管
Novo Nordisk receives European Commission approval of Wegovy pill as first oral GLP-1 for weight management in the EU
The European Commission approved Novo Nordisk's oral Wegovy (once-daily oral semaglutide 25 mg), the first oral GLP-1 approved for weight management in the EU; the EC also approved a single, ready-to-use Wegovy 7.2 mg pen for a higher dose.
大盤 開啟原文 ↗